Aktiesnakken — August 2012
-
den kommer langt op igen
-
det lukker genmabs usikkerhed af på så mange måder
-
og ingen wanker takeover
-
Udviklingsprogrammet er helt enormt stort. Janssen sætter fuld skrue på. Og genmab betaler ikke en krone
-
solsen ride it up the whole way from now
-
genmab ekploderer når vi når over kurs 150
-
Solsen dealen er dobbelt så stor som vi troede
-
hvad havde bowers dara sat til?
-
20 kkr. per aktie?
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind